Appropriateness of empirical treatment and outcome in bacteremia caused by extended-spectrum-β-lactamase-producing bacteria

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 7, 2013, Pages 3092-3099

  Frakking, Florine N J ^a,b   Rottier, Wouter C ^a   Dorigo Zetsma, J Wendelien ^c   Van Hattem, Jarne M ^c,g   Van Hees, Babette C ^d   Kluytmans, Jan A J W ^e,f   Lutgens, Suzanne P M ^e,k   Prins, Jan M ^g   Thijsen, Steven F T ^h   Verbon, Annelies ⁱ   Vlaminckx, Bart J M ^a   Stuart, James W Cohen ^a,l   Leverstein Van Hall, Maurine A ^a,j,m   Bonten, Marc J M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ST ANTONIUS HOSPITAL   (Netherlands)

^c TerGooi Hospitals   (Netherlands)

^d GELRE HOSPITALS   (Netherlands)

^e AMPHIA HOSPITAL   (Netherlands)

^f VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^g ACADEMIC MEDICAL CENTER   (Netherlands)

^h DEPARTMENT OF SURGERY   (Netherlands)

ⁱ ERASMUS MEDICAL CENTER   (Netherlands)

^j NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^k JEROEN BOSCH HOSPITAL   (Netherlands)

^l Medical Centre Alkmaar   (Netherlands)

^m MEDICAL CENTER HAAGLANDEN   (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; AMOXICILLIN; BETA LACTAM ANTIBIOTIC; CARBAPENEM; CEFTAZIDIME; CEPHALOSPORIN; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT;

ABDOMINAL INFECTION; ADOLESCENT; ADULT; AGED; ARTICLE; BACTEREMIA; CHILD; COMMUNITY ACQUIRED PNEUMONIA; COMORBIDITY; CONTROLLED STUDY; DISEASE SEVERITY; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING KLEBSIELLA PNEUMONIAE; FEMALE; HOSPITAL INFECTION; HOSPITALIZATION; HUMAN; INAPPROPRIATE PRESCRIBING; INFANT; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEOPLASM; NONHUMAN; PATIENT CODING; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEPSIS; TREATMENT OUTCOME; URINARY TRACT INFECTION;

AGED; ANTI-BACTERIAL AGENTS; BACTEREMIA; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; BETA-LACTAMS; COMORBIDITY; CROSS INFECTION; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE INFECTIONS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; INTRAABDOMINAL INFECTIONS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MICROBIAL SENSITIVITY TESTS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84879006351     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01523-12     Document Type: Article

References (37)

1. Leclercq R, Canton R, Brown DF, Giske CG, Heisig P, Macgowan AP, Mouton JW, Nordmann P, Rodloff AC, Rossolini GM, Soussy CJ, Steinbakk M, Winstanley TG, Kahlmeter G. 25 November 2011, posting date. EUCAST expert rules in antimicrobial susceptibility testing. Clin. Microbiol. Infect. doi:10.1111/j.1469-0691.2011.03703.x.
2. CLSI. 2010. Performance standards for antimicrobial susceptibility testing; twentieth informational supplement. CLSI document M100-S20. Clinical and Laboratory Standards Institute, Wayne, PA.
3. Rodríguez-Baño J, Navarro MD, Retamar P, Picón E, Pascual Á, Extended-Spectrum Beta-Lactamases-Red Española de Investigación en Patología Infecciosa/Grupo de Estudio de Infección Hospitalaria Group. 2012. β-Lactam/β-lactam inhibitor combinations for the treatment of bacteremia due to extended-spectrum β-lactamase-producing Escherichia coli: a post hoc analysis of prospective cohorts. Clin. Infect. Dis. 54:167-174.
4. Perez F, Bonomo RA. 2012. Can we really use β-lactam/β-lactam inhibitor combinations for the treatment of infections caused by extendedspectrum β-lactamase-producing bacteria? Clin. Infect. Dis. 54:175-177.
5. Rottier WC, Ammerlaan HS, Bonten MJ. 2012. Effects of confounders and intermediates on the association of bacteraemia caused by extendedspectrum beta-lactamase-producing Enterobacteriaceae and patient outcome: a meta-analysis. J. Antimicrob. Chemother. 67:1311-1320.
6. Pitout JD. 2010. Infections with extended-spectrum beta- lactamaseproducing Enterobacteriaceae: changing epidemiology and drug treatment choices. Drugs 70:313-333.
7. European Centre for Disease Prevention and Control. 2011. Antimicrobial resistance surveillance in Europe 2010. Annual report of the Eu-ropean Antimicrobial Resistance Surveillance Network (EARS-Net). European Centre for Disease Prevention and Control, Stockholm, Sweden.
8. Adriaenssens N, Coenen S, Versporten A, Muller A, Minalu G, Faes C, Vankerckhoven V, Aerts M, Hens N, Molenberghs G, Goossens H. 2011. European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe (1997-2009). J. Antimicrob. Chemother. 66(Suppl 6):vi3-vi12. doi:10.1093/jac/dkr453.
9. Kluytmans-Vandenbergh MF, Kluytmans JA, Voss A. 2005. Dutch guideline for preventing nosocomial transmission of highly resistant microorganisms (HRMO). Infection 33:309-313. (Pubitemid 41552005)
10. Frakking FNJ, Rottier WC, Dorigo W, Van Hattem J, Van Hees BC, Kluytmans JAJW, Dumont-Lutgens S, Prins JM, Thijsen SFT, Verbon A, Vlaminckx BJ, Cohen Stuart J, Leverstein-van Hall M, Bonten MJM. 2012. Abstr. 22nd Eur. Congr. Clin. Microbiol. Infect. Dis., London, United Kingdom, 3 April 2012, poster P1860.
11. Charlson ME, Pompei P, Ales KL, MacKenzie CR. 1987. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J. Chronic Dis. 40:373-383. (Pubitemid 17055592)
12. Paterson DL, Ko WC, Von Gottberg A, Mohapatra S, Casellas JM, Goossens H, Mulazimoglu L, Trenholme G, Klugman KP, Bonomo RA, Rice LB, Wagener MM, McCormack JG, Yu VL. 2004. International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum beta-lactamase production in nosocomial infections. Ann. Intern. Med. 140:26-32. (Pubitemid 38055918)
13. CLSI. 2007. Performance standards for antimicrobial susceptibility testing; seventeenth informational supplement. CLSI document M100-S17. Clinical and Laboratory Standards Institute, Wayne, PA.
14. Platteel TN, Cohen Stuart JW, de Neeling AJ, Voets GM, Scharringa J, van de Sande N, Fluit AC, Bonten MJ, Leverstein-Van Hall MA, ESBL National Surveillance Working Group. 23 January 2012, posting date. Multi-centre evaluation of a phenotypic extended spectrum betalactamase detection guideline in the routine setting. Clin. Microbiol. Infect. doi:10.1111/j.1469-0691.2011. 03739.x.
15. Friedman ND, Kaye KS, Stout JE, McGarry SA, Trivette SL, Briggs JP, Lamm W, Clark C, MacFarquhar J, Walton AL, Reller LB, Sexton DJ. 2002. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann. Intern. Med. 137:791-797. (Pubitemid 35334450)
16. Muckart DJ, Bhagwanjee S. 1997. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference definitions of the systemic inflammatory response syndrome and allied disorders in relation to critically injured patients. Crit. Care Med. 25:1789-1795. (Pubitemid 27483955)
17. Ben-Ami R, Rodríguez-Baño J, Arslan H, Pitout JD, Quentin C, Calbo ES, Azap OK, Arpin C, Pascual A, Livermore DM, Garau J, Carmeli Y. 2009. A multinational survey of risk factors for infection with extendedspectrum beta-lactamase-producing Enterobacteriaceae in nonhospitalized patients. Clin. Infect. Dis. 49:682-690.
18. Rodríguez-Baño J, Alcalá JC, Cisneros JM, Grill F, Oliver A, Horcajada JP, Tórtola T, Mirelis B, Navarro G, Cuenca M, Esteve M, Peña C, Llanos AC, Cantón R, Pascual A. 2008. Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. Arch. Intern. Med. 168:1897-1902.
19. Tängdén T, Cars O, Melhus A, Löwdin E. 2010. Foreign travel is a major risk factor for colonization with Escherichia coli producing CTX-M-type extended-spectrum beta-lactamases: a prospective study with Swedish volunteers. Antimicrob. Agents Chemother. 54:3564-3568.
20. Laupland KB, Church DL, Vidakovich J, Mucenski M, Pitout JD. 2008. Community-onset extended-spectrum beta-lactamase (ESBL) producing Escherichia coli: importance of international travel. J. Infect. 57:441-448.
21. Paterson DL, Bonomo RA. 2005. Extended-spectrum beta-lactamases: a clinical update. Clin. Microbiol. Rev. 18:657-686.
22. Dutch Working Party on Antibiotic Policy. 2010. SWAB guidelines for antibacterial therapy of adult patients with sepsis. SWAB, Amsterdam, the Netherlands.
23. Paul M, Shani V, Muchtar E, Kariv G, Robenshtok E, Leibovici L. 2010. Systematic review and meta-analysis of the efficacy of appropriate empiric antibiotic therapy for sepsis. Antimicrob. Agents Chemother. 54:4851-4863.
24. Vallés J, Rello J, Ochagavía A, Garnacho J, Alcalá MA. 2003. Community-acquired bloodstream infection in critically ill adult patients: impact of shock and inappropriate antibiotic therapy on survival. Chest 123: 1615-1624. (Pubitemid 36549784)
25. Ibrahim EH, Sherman G, Ward S, Fraser VJ, Kollef MH. 2000. The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 118:146-155. (Pubitemid 30485502)
26. Tumbarello M, Sali M, Trecarichi EM, Leone F, Rossi M, Fiori B, De Pascale G, D'Inzeo T, Sanguinetti M, Fadda G, Cauda R, Spanu T. 2008. Bloodstream infections caused by extended-spectrum-beta-lactamaseproducing Escherichia coli: risk factors for inadequate initial antimicrobial therapy. Antimicrob. Agents Chemother. 52:3244-3252.
27. Tumbarello M, Sanguinetti M, Montuori E, Trecarichi EM, Posteraro B, Fiori B, Citton R, D'Inzeo T, Fadda G, Cauda R, Spanu T. 2007. Predictors of mortality in patients with bloodstream infections caused by extended-spectrum- beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment. Antimicrob. Agents Chemother. 51:1987-1994. (Pubitemid 46903084)
28. Rodríguez-Baño J, Picón E, Gijón P, Hernández JR, Cisneros JM, Peña C, Almela M, Almirante B, Grill F, Colomina J, Molinos S, Oliver A, Fernández-Mazarrasa C, Navarro G, Coloma A, López-Cerero L, Pascual A. 2010. Risk factors and prognosis of nosocomial bloodstream infections caused by extended-spectrum-beta-lactamase- producing Escherichia coli. J. Clin. Microbiol. 48:1726-1731.
29. Kang CI, Kim SH, Park WB, Lee KD, Kim HB, Kim EC, Oh MD, Choe KW. 2004. Bloodstream infections due to extended-spectrum betalactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy. Antimicrob. Agents Chemother. 48:4574-4581.
30. Chung HC, Lai CH, Lin JN, Huang CK, Liang SH, Chen WF, Shih YC, Lin HH, Wang JL. 2012. Bacteremia caused by extended-spectrum-betalactamase-producing Escherichia coli sequence type ST131 and non-ST131 clones: comparison of demographic data, clinical features, and mortality. Antimicrob. Agents Chemother. 56:618-622.
31. De Rosa FG, Pagani N, Fossati L, Raviolo S, Cometto C, Cavallerio P, Parlato C, Guglielmi E, Serra R, Di Perri G. 2011. The effect of inappropriate therapy on bacteremia by ESBL-producing bacteria. Infection 39:555-561.
32. Wang SS, Lee NY, Hsueh PR, Huang WH, Tsui KC, Lee HC, Wu CJ, Chang CM, Huang CC, Huang CF, Ko WC. 2011. Clinical manifestations and prognostic factors in cancer patients with bacteremia due to extended-spectrum beta-lactamase- producing Escherichia coli or Klebsiella pneumoniae. J. Microbiol. Immunol. Infect. 44:282-288.
33. Marchaim D, Gottesman T, Schwartz O, Korem M, Maor Y, Rahav G, Karplus R, Lazarovitch T, Braun E, Sprecher H, Lachish T, Wiener-Well Y, Alon D, Chowers M, Ciobotaro P, Bardenstein R, Paz A, Potasman I, Giladi M, Schechner V, Schwaber MJ, Klarfeld-Lidji S, Carmeli Y. 2010. National multicenter study of predictors and outcomes of bacteremia upon hospital admission caused by Enterobacteriaceae producing extended-spectrum β-lactamases. Antimicrob. Agents Chemother. 54:5099-5104.
34. Ortega M, Marco F, Soriano A, Almela M, Martínez JA, Muñoz A, Mensa J. 2009. Analysis of 4758 Escherichia coli bacteraemia episodes: predictive factors for isolation of an antibiotic-resistant strain and their impact on the outcome. J. Antimicrob. Chemother. 63:568-574.
35. Peña C, Pujol M, Ardanuy C, Ricart A, Pallarés R, Liñares J, Ariza J, Gudiol F. 2001. An outbreak of hospital-acquired Klebsiella pneumoniae bacteraemia, including strains producing extended-spectrum betalactamase. J. Hosp. Infect. 47:53-59.
36. Daikos GL, Kosmidis C, Tassios PT, Petrikkos G, Vasilakopoulou A, Psychogiou M, Stefanou I, Avlami A, Katsilambros N. 2007. Enterobacteriaceae bloodstream infections: presence of integrons, risk factors, and outcome. Antimicrob. Agents Chemother. 51:2366-2372. (Pubitemid 47047312)
37. van der Bij AK, Peirano G, Goessens WH, van der Vorm ER, van Westreenen M, Pitout JD. 2011. Clinical and molecular characteristics of extended-spectrum-beta-lactamase-producing Escherichia coli causing bacteremia in the Rotterdam area, Netherlands. Antimicrob. Agents Chemother. 55:3576-3578.